Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.

The efficacy of oral WIN 54954 for the prevention of rhinovirus infection and illness was tested in two randomized, double-blinded, placebo-controlled volunteer challenge studies. Volunteers were inoculated with rhinovirus type 39 (MIC of WIN 54954, 0.17 microgram/ml) or rhinovirus type 23 (MIC, 0.0...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Turner, R B, Dutko, F J, Goldstein, N H, Lockwood, G, Hayden, F G
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1993
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187656/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8383943/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.297
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!